Data from Aβ precursor protein (APP) transgenic mouse model supported the essential role of gut microbiota in AD development as a remarkable shift in the gut microbiota was accompanied with an obvious reduction in cerebral Aβ amyloid pathology (Harach et al., 2017). This evidence concerns the gene APP and Alzheimer disease.